A detailed history of Christensen, King & Associates Investment Services, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Christensen, King & Associates Investment Services, Inc. holds 1,152 shares of LLY stock, worth $861,707. This represents 0.48% of its overall portfolio holdings.

Number of Shares
1,152
Previous 1,215 5.19%
Holding current value
$861,707
Previous $1.1 Billion 7.22%
% of portfolio
0.48%
Previous 0.54%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$772.14 - $960.02 $48,644 - $60,481
-63 Reduced 5.19%
1,152 $1.02 Billion
Q1 2024

Aug 08, 2024

SELL
$592.2 - $792.28 $36,124 - $48,329
-61 Reduced 4.78%
1,215 $945 Million
Q4 2023

Aug 08, 2024

BUY
$525.19 - $619.13 $670,142 - $790,009
1,276 New
1,276 $744 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Christensen, King & Associates Investment Services, Inc. Portfolio

Follow Christensen, King & Associates Investment Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Christensen, King & Associates Investment Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Christensen, King & Associates Investment Services, Inc. with notifications on news.